BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

803 related articles for article (PubMed ID: 8543829)

  • 41. Complement activation by immunoglobulin does not depend solely on C1q binding.
    Bindon CI; Hale G; Waldmann H
    Eur J Immunol; 1990 Feb; 20(2):277-81. PubMed ID: 2311645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antigenic modulation of the cytophilic binding of guinea-pig IgG and IgM antibodies to homologous macrophages.
    Webster RO; Lawrence DA
    Immunology; 1979 Apr; 36(4):659-70. PubMed ID: 86509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unusual complement activation properties of serum immunoglobulins of the pigeon Columba livia.
    Koppenheffer TL; Russell BA
    Immunology; 1986 Mar; 57(3):473-8. PubMed ID: 3957409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of circulating immune complexes in patients with atopic dermatitis and psoriasis.
    Kapp A; Kemper A; Schöpf E; Deicher H
    Acta Derm Venereol; 1986; 66(2):121-6. PubMed ID: 2424234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunoglobulin and complement depositions in the liver of chronic hepatitis patients.
    Vasei M; Monabbati A; Alizadeh-Naeeni M; Houshmand S; Azarpira N; Lankarani KB; Mosallaee M; Taghavi Sa; Geramizadeh B; Saberi-Firouzi M; Imaniyeh MH
    Hepatogastroenterology; 2008; 55(84):1066-70. PubMed ID: 18705329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polyclonal IgM and IgA block in vitro complement deposition mediated by anti-ganglioside antibodies in autoimmune neuropathies.
    Sudo M; Miyaji K; Späth PJ; Morita-Matsumoto K; Yamaguchi Y; Yuki N
    Int Immunopharmacol; 2016 Nov; 40():11-15. PubMed ID: 27567246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High doses of intravenous Ig inhibit in vitro uptake of C4 fragments onto sensitized erythrocytes.
    Basta M; Fries LF; Frank MM
    Blood; 1991 Jan; 77(2):376-80. PubMed ID: 1985703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of specific antibody on antibody-independent interactions between E. coli J5 and human complement.
    Betz SJ; Page N; Estrade C; Isliker H
    J Immunol; 1982 Feb; 128(2):707-11. PubMed ID: 7033382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Concentration of complement C3 and C4 in sera containing monoclonal IgA or IgG].
    Bartelik S
    Przegl Lek; 1990; 47(2):265-7. PubMed ID: 2356335
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Simultaneous detection of IgG, IgM, IgA complexes and C3d attached to erythrocytes by flow cytometry.
    Alzate MA; Manrique LG; Bolaños NI; Duarte M; Coral-Alvarado P; González JM
    Int J Lab Hematol; 2015 Jun; 37(3):382-9. PubMed ID: 25269888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tetanus toxoid-anti-tetanus toxoid complexes: a potential model to study the complement transport system for immune complex in humans.
    Paccaud JP; Steiger G; Sjöholm AG; Spaeth PJ; Schifferli JA
    Clin Exp Immunol; 1987 Aug; 69(2):468-76. PubMed ID: 2958199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.
    Takata Y; Tamura N; Fujita T
    J Immunol; 1984 May; 132(5):2531-7. PubMed ID: 6232320
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of C1, C1-inactivator and C4 in modulating immune precipitation.
    Schifferli JA; Steiger G; Schapira M
    Clin Exp Immunol; 1985 Jun; 60(3):605-12. PubMed ID: 4017288
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunologic studies of human schistosomiasis. I. Clinical and immunological findings in acute and chronic schistosomiasis.
    El-Din AH; Peters SM; Attia WM; Liu WJ; El-Tawil G; Ali MH; Bellanti JA
    Ann Allergy; 1983 Mar; 50(3):182-9. PubMed ID: 6829984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Secretory IgA and complement levels in patients with hookworm infection in Zaria.
    Musa BO; Onyemelukwe GC
    Afr J Med Med Sci; 2000 Jun; 29(2):111-4. PubMed ID: 11379439
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Binding to erythrocyte complement receptor type 1 of BSA/anti-BSA complexes opsonized by C4A3 or C4B1 in the presence of serum.
    Klint C; Truedsson L; Sturfelt G
    Scand J Immunol; 1995 Oct; 42(4):425-32. PubMed ID: 7569775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Measurements of nonspecific humoral immune parameters in patients with chronic pyelonephritis.
    Stein G; Stelzner A
    Clin Nephrol; 1981 Apr; 15(4):185-93. PubMed ID: 7237865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Converse changes in serum levels of immunoglobulins (IgG, A and M) and complement components (C3, 4) during pregnancy].
    Yasuhara M; Tamaki H; Iyama S; Yamaguchi Y; Amino N; Miyai K
    Rinsho Byori; 1991 Nov; 39(11):1195-8. PubMed ID: 1762197
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of rat complement by soluble and insoluble immune complexes of rat IgA.
    Rits M; Hiemstra PS; Bazin H; van Es LA; Daha M; Vaerman JP
    Monogr Allergy; 1988; 24():129-33. PubMed ID: 3362139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.